A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 767 shares of TMO stock, worth $394,391. This represents 0.3% of its overall portfolio holdings.

Number of Shares
767
Previous 767 -0.0%
Holding current value
$394,391
Previous $424,000 11.79%
% of portfolio
0.3%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $76,429 - $91,467
-150 Reduced 16.36%
767 $438,000
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $249,359 - $300,812
917 New
917 $298,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Creegan & Nassoura Financial Group, LLC Portfolio

Follow Creegan & Nassoura Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.